BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹15,262 Cr | ₹14,756 Cr | ₹11,174 Cr | ₹8,184 Cr | ₹7,143 Cr |
What is the latest Revenue of BIOCON ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹15,262 Cr |
| Mar2024 | ₹14,756 Cr |
| Mar2023 | ₹11,174 Cr |
| Mar2022 | ₹8,184 Cr |
| Mar2021 | ₹7,143 Cr |
How is Revenue of BIOCON Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹15,262 Cr | 3.43 | |
| Mar2024 | ₹14,756 Cr | 32.05 | |
| Mar2023 | ₹11,174 Cr | 36.54 | |
| Mar2022 | ₹8,184 Cr | 14.57 | |
| Mar2021 | ₹7,143 Cr | - | |
Compare Revenue of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹56,674.8 Cr | -2.5% | -8.2% | 7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -2.5% |
-8.2% |
7.8% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses